F
Fabien Zoulim
Researcher at French Institute of Health and Medical Research
Publications - 716
Citations - 40988
Fabien Zoulim is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Hepatitis B virus & Hepatitis B. The author has an hindex of 96, co-authored 641 publications receiving 35807 citations. Previous affiliations of Fabien Zoulim include Hotel Dieu Hospital & University of Orléans.
Papers
More filters
Journal ArticleDOI
Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.
Anders Boyd,Raoul Moh,Sarah Maylin,M Abdou Chekaraou,Nadia Mahjoub,Delphine Gabillard,Delphine Gabillard,Xavier Anglaret,Xavier Anglaret,Serge-Paul Eholié,Constance Delaugerre,Constance Delaugerre,Christine Danel,Christine Danel,Fabien Zoulim,Fabien Zoulim,Karine Lacombe,Anrs VarBVA study +17 more
TL;DR: The nucleotide substitution G1896A on the precore (pc) region has been implicated in virological and serological responses during treatment in hepatitis B virus (HBV)-infected patients as discussed by the authors.
Journal ArticleDOI
Does occult HBV infection have an impact on the evolution of chronic hepatitis C
TL;DR: A long awaited observational cohort study evaluating the clinical evolution of chronic hepatitis C patients according to their OBI status and concludes that OBI is highly prevalent in patients with CHC, at least in areas of high HBV prevalence.
Journal ArticleDOI
Hepatic inflammation elicits production of proinflammatory netrin‐1 through exclusive activation of translation
Romain Barnault,Claire Verzeroli,Carole Fournier,Maud Michelet,Anna Rita Redavid,Ievgeniia Chicherova,Marie-Laure Plissonnier,Annie Adrait,Olga A. Khomich,Fleur Chapus,M Richaud,Maëva Hervieu,Veronika Reiterer,Federica Grazia Centonze,Julie Lucifora,Birke Bartosch,Michel Rivoire,Hesso Farhan,Yohann Couté,Valbona Mirakaj,Thomas Decaens,Patrick Mehlen,Benjamin Gibert,Fabien Zoulim,Romain Parent +24 more
TL;DR: Netrin‐1 displays protumoral properties, though the pathological contexts and processes involved in its induction remain understudied, and the liver is a major model of inflammation‐associated cancer development, leading to HCC.
Journal ArticleDOI
Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance.
Nathalie Ganne-Carrié,Nathalie Ganne-Carrié,Pierre Nahon,Pierre Nahon,Cendrine Chaffaut,Gisèle N'Kontchou,Richard Layese,Etienne Audureau,Sylvie Chevret,Isabelle Archambeaud,Louis d’Alteroche,Frédéric Oberti,Dominique Roulot,Christophe Moreno,Alexandre Louvet,Thong Dao,Romain Moirand,Odile Goria,Eric Nguyen-Khac,Nicolas Carbonell,Jean-Charles Duclos-Vallée,Stanislas Pol,Stanislas Pol,Victor de Ledinghen,Violaine Ozenne,Jean Henrion,Jean-Marie Péron,Albert Tran,Gabriel Perlemuter,Xavier Amiot,Jean-Pierre Zarski,Tarik Asselah,Dominique Guyader,Hélène Fontaine,Georges-Philippe Pageaux,Denis Ouzan,Fabien Zoulim,Jean-Pierre Bronowicki,Thomas Decaens,Ghassan Riachi,Paul Calès,Laurent Alric,Marc Bourlière,Philippe Mathurin,Sébastien Dharancy,Jean-Frédéric Blanc,Armand Abergel,Olivier Chazouillères,Ariane Mallat,Jean-Didier Grangé,Pierre Attali,Claire Wartelle,Dominique Thabut,Christophe Pilette,Christine Silvain,Christos Christidis,Brigitte Bernard-Chabert,Sophie Hillaire,Vincent Di Martino +58 more
TL;DR: Compared to patients with virus-related cirrhosis, patients with alcohol-related compensated CirVir enrolled in a surveillance program have a lowest five-year HCC incidence and poorer prognosis, despite similar access to first-line curative treatment.
Journal ArticleDOI
Données actuelles sur le traitement de l’hépatite B chronique
TL;DR: The developpement de nouvelles options therapeutiques, le traitement des hepatites B chroniques demeure un defi clinique, du fait de la necessite de traitements prolonges chez la majorite des patients as discussed by the authors.